Literature DB >> 23140834

Oxidation matters: the ubiquitin proteasome system connects innate immune mechanisms with MHC class I antigen presentation.

Annika Warnatsch1, Theresa Bergann, Elke Krüger.   

Abstract

During innate immune responses the delicate balance of protein synthesis, quality control and degradation is severely challenged by production of radicals and/or the massive synthesis of pathogen proteins. The regulated degradation of ubiquitin-tagged proteins by the ubiquitin proteasome system (UPS) represents one major pathway for the maintenance of cellular proteostasis and regulatory processes under these conditions. In addition, MHC class I antigen presentation is strictly dependent on an appropriate peptide supply by the UPS to efficiently prime CD8(+) T cells and to initiate an adaptive immune response. We here discuss recent efforts in defining the link between innate immune mechanisms like cytokine and ROS production, the induction of an efficient adaptive immune response and the specific involvement of the UPS therein. Cytokines and/or infections induce translation and the production of free radicals, which in turn confer oxidative damage to nascent as well as folded proteins. In parallel, the same signaling cascades are able to accelerate the protein turnover by the concomitantly induced ubiquitin conjugation and degradation of such damaged polypeptides by immunoproteasomes. The ability of immunoproteasomes to efficiently degrade such oxidant-damaged ubiquitylated proteins protects cells from accumulating toxic ubiquitin-rich aggregates. At the same time, this innate immune mechanism facilitates a sufficient peptide supply for MHC class I antigen presentation and connects it to initiation of adaptive immunity.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23140834     DOI: 10.1016/j.molimm.2012.10.007

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  13 in total

Review 1.  [Clinical aspects and genetics of proteasome-associated autoinflammatory syndromes (PRAAS)].

Authors:  E Feist; A Brehm; T Kallinich; E Krüger
Journal:  Z Rheumatol       Date:  2017-05       Impact factor: 1.372

2.  Identification of Biomarkers Associated With CD8+ T Cells in Coronary Artery Disease and Their Pan-Cancer Analysis.

Authors:  Shijian Zhao; Yinteng Wu; Yantao Wei; Xiaoyu Xu; Jialin Zheng
Journal:  Front Immunol       Date:  2022-06-21       Impact factor: 8.786

3.  Dopamine signaling promotes the xenobiotic stress response and protein homeostasis.

Authors:  Kishore K Joshi; Tarmie L Matlack; Christopher Rongo
Journal:  EMBO J       Date:  2016-06-03       Impact factor: 11.598

Review 4.  Dysfunction in protein clearance by the proteasome: impact on autoinflammatory diseases.

Authors:  Anja Brehm; Elke Krüger
Journal:  Semin Immunopathol       Date:  2015-05-12       Impact factor: 11.759

Review 5.  The immunoproteasome and viral infection: a complex regulator of inflammation.

Authors:  Mary K McCarthy; Jason B Weinberg
Journal:  Front Microbiol       Date:  2015-01-29       Impact factor: 5.640

Review 6.  Trial Watch: Proteasomal inhibitors for anticancer therapy.

Authors:  Florine Obrist; Gwenola Manic; Guido Kroemer; Ilio Vitale; Lorenzo Galluzzi
Journal:  Mol Cell Oncol       Date:  2014-12-01

Review 7.  PERM Hypothesis: The Fundamental Machinery Able to Elucidate the Role of Xenobiotics and Hormesis in Cell Survival and Homeostasis.

Authors:  Salvatore Chirumbolo; Geir Bjørklund
Journal:  Int J Mol Sci       Date:  2017-01-15       Impact factor: 5.923

8.  Biogenic amine neurotransmitters promote eicosanoid production and protein homeostasis.

Authors:  Kishore K Joshi; Tarmie L Matlack; Stephanie Pyonteck; Mehul Vora; Ralph Menzel; Christopher Rongo
Journal:  EMBO Rep       Date:  2021-01-20       Impact factor: 8.807

9.  Dysregulation of the (immuno)proteasome pathway in malformations of cortical development.

Authors:  J van Scheppingen; D W M Broekaart; T Scholl; M R J Zuidberg; J J Anink; W G Spliet; P C van Rijen; T Czech; J A Hainfellner; M Feucht; A Mühlebner; E A van Vliet; E Aronica
Journal:  J Neuroinflammation       Date:  2016-08-26       Impact factor: 8.322

Review 10.  ROS and ROS-Mediated Cellular Signaling.

Authors:  Jixiang Zhang; Xiaoli Wang; Vikash Vikash; Qing Ye; Dandan Wu; Yulan Liu; Weiguo Dong
Journal:  Oxid Med Cell Longev       Date:  2016-02-22       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.